Abstract
Macrophage migration inhibitory factor (MIF) is an important pro-inflammatory cytokine expressed at sites of inflammation. We have assessed this factor (MIF) in urinary tract infections with the aim of determining a non-invasive and sensitive method to differentiate upper and lower renal involvement. Thirty-three pediatric patients with urinary track infection (25 with acute pyelonephritis, eight with acute cystitis) and 40 healthy subjects were recruited for this prospective case–control study. Pyelonephritis was differentiated from cystitis by dimercaptosuccinic acid (DMSA) scan. Urinary MIF concentration was determined using an enzyme-linked immunosorbent assay method. The urine MIF/creatinine (Cr) ratio was significantly higher in pyelonephritis patients than in those with acute cystitis and the control group (P < 0.001). The optimal cut-point of 4.90 pg/µmol Cr for the urine MIF/Cr ratio has the potential to be a biomarker for distinguishing patients with acute pyelonephritis from those with acute cystitis. Determination of the urinary MIF was also useful in selecting the patients at risk of permanent renal damage. Of those patients with pyelonephritis, based on the DMSA scan at the time of infection, scarring on follow-up DMSA scan 9–12 months later occurred in patients with the highest urinary MIF/Cr ratios. We conclude that the urine MIF/Cr ratio is a sensitive test for differentiating acute pyelonephritis from acute cystitis and also for detecting children with acute pyelonephritis who are at a higher risk for permanent renal scars in the future.
Similar content being viewed by others
References
Criag JC, Wheeler DM, Irwig L (2000) How accurate is dimercatosuccinic acid scintigraphy for the diagnosis of acute pyelonephritis? A meta-analysis of experimental studies. J Nuclear Med 41:986–993
Martinelli J, Claesson I, Lidin-Janson G, Jodal U (1995) Urinary infection, reflux and renal scarring in females continuously followed for 13–38 years. Pediatr Nephrol 9:131–136
Smellie J, Edwards D, Hunter N, Normand ICS, Prescod N (1975) Vesicoureteral reflux and renal scarring. Kidney Int 8:565–575
Rushton HG (1997) The evaluation of acute pyelonephritis and renal scarring with technetium 99m-dimercaptosuccinic acid renal scintigraphy: evolving concepts and future directions. Pediatr Nephrol 11:108–120
Hoberman A, Wald ER, Hickey RW, Baskin M, Charron M, Majd M, Kearney DH, Reynolds EA, Ruley J, Janosky JE (1999) Oral versus initial intravenous therapy for urinary tract infections in young febrile children. Pediatrics 104:79–86
Jakobsson B, Soderlundh S, Berg U (1992) Diagnostic significance of 99mTc-dimercaptosuccinic acid (DMSA) scintigraphy in urinary tract infection. Arch Dis Child 67:1338–1342
Benador D, Benador N, Slosman DO, Nussle D, Mermillod B, Girardin E (1994) Cortical scintigraphy in the evaluation of renal parenchymal changes in children with pyelonephritis. J Pediatr 124:17–20
Ataei N, Madani A, Habibi R, Khorasani M (2005) Evaluation of acute pyelonephritis with DMSA scans in children presenting after the age of 5 years. Pediatr Nephrol 20:1439–1444
Morand EF, Bucala R, Leech M (2003) Macrophage migration inhibitory factor: an emerging therapeutic target in rheumatoid arthritis. Arthritis Rheum 48:291–299
Bacher M, Metz CN, Calandra T, Mayer K, Chesney J, Lohoff M, Gemsa D, Donnelly T, Bucala R (1996) An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci USA 93:7849–7854
Metz CN, Bucala R (1997) Role of macrophage migration inhibitory factor in the regulation of the immune response. Adv Immunol 66:197–223
Metz CN, Bucala R (2001) MIF. In: Oppenheim JJ, Feldman M (eds) Cytokine reference: a compendium of cytokines and other mediators of host defense, vol 1. Academic Press, San Diego, pp 703–716
Huang XR, Hui CWC, Chen Y-X, Chun B, Wong Y, Fung PCW, Metz C, Cho CH, Hui WM, Bucala R, Lam S-K, Lan HY (2001) Macrophage migration inhibitory factor is an important mediator in the pathogenesis of gastric inflammation in rats. Gastroenterology 121:619–630
Ohkawara T, Nishihira J, Takeda J, Hige S, Kato M, Sugiyama T, Iwanaga T, Nakamura H, Mizue Y, Asaka M (2002) Amelioration of dextran sulfate sodium-induced colitis by anti-macrophage migration inhibitory factor antibody in mice. Gastroenterology 123:256–270
Bacher M, Meinhardt A, Lan HY, Dhabhar FS, Mu W, Metz CN, Chesney JA, Gemsa D, Donnelly T, Atkins RC, Bucala R (1998) MIF expression in the rat brain: implications for neuronal function. Mol Med 4:217–230
Vera PL, Iczkowski KA, Leng L, Bucala R, Meyer-Siegler KL (2005) Macrophage migration inhibitory factor is released as a complex with alpha1-inhibitor-3 in the intraluminal fluid during bladder inflammation in the rat. J Urol 174:338–343
Meyer-Siegler KL, Iczkowski KA, Vera PL (2006) Macrophage migration inhibitory factor is increased in the urine of patients with urinary tract infection: macrophage migration inhibitory factor-protein complexes in human urine. J Urol 175:1523–1528
Vera PL, Meyer-Siegler KL (2003) Anatomical location of macrophage migration inhibitory factor in urogenital tissues, peripheral ganglia and lumbosacral spinal cord of the rat. BMC Neurosci 4:17
Hansson S, Jodal U (2004) Urinary tract infection. In: Avner E, Harmon W, Niaudet P (eds) Pediatric nephrology, 5th edn. Williams & Wilkins, Philadelphia, pp 1007–1026
Knapp RG, Miller MC (eds) (1992) Describing the performance of a diagnostic test. In: Knapp RG, Miller MC (eds) Clinical epidemiology and biostatistics, 1st edn. Williams & Wilkins, Baltimore, pp 41–42
Calandra T, Bernhagen J, Mitchell RA, Bucala R (1994) The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 179:1895–1902
Nishino T, Bernhagen J, Shiiki H, Calandra T, Dohi K, Bucala R (1995) Localisation of macrophage migration inhibitory factor (MIF) to secretory granules within the corticotrophic and thyrotrophic cells of the pituitary gland. Mol Med 1:781–788
Bacher M, Meinhardt A, Lan HY, Mu W, Metz CN, Chesney JA, Calandra T, Gemsa D, Donnelly T, Atkins RC, Bucala R (1997) Migration inhibitory factor expression in experimentally induced endotoxemia. Am J Pathol 150:235–246
Meinhardt A, Bacher M, McFarlane JR, Metz CN, Seitz J, Hedger MP, de Kretser DM, Bucala R (1996) Macrophage migration inhibitory factor production by Leydig cells: Evidence for a role in the regulation of testicular function. Endocrinology 137:5090–5095
Waeber G, Calandra T, Roduit R, Haefliger JA, Bonny C, Thompson N, Thorens B, Temler E, Meinhardt A, Bacher M, Metz CN, Nicod P, Bucala R (1997) Insulin secretion is regulated by the glucose-dependent production of islet beta cell macrophage migration inhibitory factor. Proc Natl Acad Sci USA 94:4782–4787
Bacher M, Meinhardt A, Lan HY, Dhabhar FS, Mu W, Metz CN, Chesney JA, Gemsa D, Donnelly T, Atkins RC, Bucala R (1998) MIF expression in the rat brain: Implications for neuronal function. Mol Med 4:217–230
Rossi AG, Haslett C, Hirani N, Greening AP, Rahman I, Metz CN, Bucala R, Donnelly SC (1998) Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF). Potential role in asthma. J Clin Invest 101:2869–2874
Steinhoff M, Meinhardt A, Steinhoff A, Gemsa D, Bucala R, Bacher M (1999) Evidence for a role of macrophage migration inhibitory factor in psoriatic skin disease. Br J Dermatol 141:1061–1066
Lan HY, Yang N, Metz C, Mu W, Song Q, Nikolic-Paterson DJ, Bacher M, Bucala R, Atkins RC (1997) TNF-alpha up-regulates renal MIF expression in rat crescentic glomerulonephritis. Mol Med 3:136–144
Miyazaki K, Isbel NM, Lan HY, Hattori M, Ito K, Bacher M, Bucala R, Atkins RC, Nikolic-Paterson DJ (1997) Up-regulation of macrophage colony-stimulating factor (M-CSF) and migration inhibitory factor (MIF) expression and monocyte recruitment during lipid-induced glomerular injury in the exogenous hypercholesterolaemic (ExHC) rat. Clin Exp Immunol 108:318–323
Song Q, Nikolic-Paterson DJ, Atkins RC, Bacher M, Bucala R, Lan HY (1998) Delayed-type hypersensitivity mediates Bowman’s capsule rupture in Tamm-Horsfall protein-induced tubulointerstitial nephritis in the rat. Nephrology 2:417–427
Tesch GH, Nikolic-Paterson DJ, Metz CN, Mu W, Bacher M, Bucala R, Atkins RC, Lan HY (1998) Rat mesangial cells express macrophage migration inhibitory factor in vitro and in vivo. J Am Soc Nephrol 9:417–424
Meyer-Siegler KL, Ordorica RC, Vera PL (2004) Macrophage migration inhibitory factor is upregulated in an endotoxin-induced model of bladder inflammation in rats. J Interferon Cytokine Res 24:55–63
Vera PL, Ordorica RC, Meyer-Siegler KL (2003) Hydrochloric acid-induced changes in macrophage migration inhibitory factor in the bladder, peripheral and central nervous system of the rat. J Urol 170:623–627
Hertting O, Khalil A, Jaremko G, Chromek M, Li YH, Bakhiet M, Bartfai T, Tullus K, Brauner A (2003) Enhanced chemokine response in experimental acute Escherichia coli pyelonephritis in IL-1β-deficient mice. Clin Exp Immunol 131:225–233
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Otukesh, H., Fereshtehnejad, SM., Hoseini, R. et al. Urine macrophage migration inhibitory factor (MIF) in children with urinary tract infection: a possible predictor of acute pyelonephritis. Pediatr Nephrol 24, 105–111 (2009). https://doi.org/10.1007/s00467-008-0969-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-008-0969-9